Peg-Interferon Alfa 2A



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Chronic Hepatitis C 39.1%
Hepatitis C 37.8%
Product Used For Unknown Indication 3.9%
Hepatic Cirrhosis 3.4%
Hypertension 3.1%
Chronic Hepatitis B 1.6%
Depression 1.6%
Hiv Infection 1.4%
Prophylaxis 1.2%
Hepatitis B 1.1%
Diabetes Mellitus 0.9%
Insomnia 0.7%
Chronic Myeloid Leukaemia 0.7%
Malignant Melanoma 0.7%
Anxiety 0.6%
Anaemia 0.5%
Prophylaxis Against Transplant Rejection 0.5%
Gastritis 0.4%
Hypothyroidism 0.4%
Pain 0.4%
White Blood Cell Count Decreased 12.1%
Thrombocytopenia 11.3%
Hepatitis C 9.1%
Syncope 8.3%
Pancytopenia 7.3%
Vomiting 6.2%
Weight Decreased 5.6%
Viral Load Increased 5.1%
Sepsis 4.3%
Death 4.0%
Pyrexia 4.0%
Rash 3.5%
Leukopenia 3.2%
Renal Failure 3.0%
Autoimmune Hepatitis 2.4%
Deep Vein Thrombosis 2.2%
Hepatocellular Carcinoma 2.2%
Pneumonia 2.2%
Urinary Tract Infection 2.2%
Neutropenia 1.9%
Secondary
Chronic Hepatitis C 31.6%
Hepatic Cirrhosis 26.6%
Hepatitis C 21.0%
Prophylaxis 3.3%
Hypertension 3.2%
Product Used For Unknown Indication 2.1%
Hiv Infection 2.0%
Gastritis 1.9%
Hepatitis B 1.2%
Thrombocytopenia 1.2%
Chronic Hepatitis B 1.0%
Insomnia 1.0%
Chronic Myeloid Leukaemia 0.6%
Immunosuppression 0.6%
Pruritus 0.6%
Myelofibrosis 0.5%
Oropharyngeal Pain 0.5%
Anxiety 0.5%
Depression 0.4%
Influenza Like Illness 0.4%
White Blood Cell Count Decreased 25.2%
Pyrexia 11.0%
Thrombocytopenia 8.0%
Hepatitis C 7.4%
Leukopenia 6.1%
Syncope 4.9%
Viral Load Increased 4.9%
Pancytopenia 3.7%
Sepsis 3.7%
Weight Decreased 3.7%
Vomiting 3.1%
Anaemia 2.5%
Neutrophil Count Decreased 2.5%
Rash 2.5%
Renal Failure 2.5%
Urinary Tract Infection 2.5%
Suicidal Ideation 1.8%
Tremor 1.8%
Ascites 1.2%
Ataxia 1.2%
Concomitant
Chronic Hepatitis C 35.3%
Hepatitis C 27.5%
Hypertension 9.8%
Prophylaxis 9.8%
Occupational Asthma 3.9%
Anaemia Of Chronic Disease 2.0%
Anxiety 2.0%
Constipation 2.0%
Insomnia 2.0%
Neck Pain 2.0%
Off Label Use 2.0%
Pain 2.0%
Hepatitis C 21.4%
Vomiting 14.3%
Cytomegalovirus Test 7.1%
Haemoglobinuria 7.1%
Haemorrhage Intracranial 7.1%
No Therapeutic Response 7.1%
Pancytopenia 7.1%
Rash Generalised 7.1%
Tooth Abscess 7.1%
Viraemia 7.1%
Viral Load Increased 7.1%
Interacting
Hepatitis C 80.0%
Hiv Infection 20.0%
Proteinuria 100.0%